VIRGINIE LEJEUNE: Open Payments
NPI 1497524128 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,462 in 121 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,805 · 2025 $2,462
Food & beverage: $2,462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $464 |
| Janssen Biotech, Inc. | 10 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $184 |
| Ardelyx, Inc. | 11 | $165 |
| Madrigal Pharmaceuticals | 9 | $164 |
| QOL Medical, LLC | 6 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $156 |
| Ipsen Biopharmaceuticals, Inc | 5 | $146 |
| Lilly USA, LLC | 6 | $130 |
| Novo Nordisk Inc | 1 | $125 |
Products named: TREMFYA, RINVOQ, IBSRELA, REZDIFFRA, Sucraid, ENTYVIO, XIFAXAN, IQIRVO.
Industry payments across FL — which companies pay providers there.
